…And Amgen Makes Three: Another Ustekinumab Biosimilar Gets Go-Ahead In EU
Third Stelara Rival, Wezenla, Receives Positive Opinion From EMA’s CHMP In April Meeting
• By David Wallace
Three Stelara biosimilars have now been cued up in Europe • Source: Shutterstock 
